Cerity Partners LLC

Position in FATE — Fate Therapeutics Inc

CIK 1566475 NEW YORK, NY

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$136,251

+$84,813 QoQ

Shares Held

113,544

+116.3% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 49.280455153949134.ToString("F0")% Shared 10.388043401676883.ToString("F0")% None 40.331501444373984.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cerity Partners LLC holds $355,640,511 across 116 Biotechnology names. FATE ranks #82 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	296,654	$132,467,876
2	REGN	Regeneron Pharmaceuticals, Inc.	43,972	$33,974,525
3	CORT	Corcept Therapeutics Inc	731,689	$29,494,383
4	HALO	Halozyme Therapeutics, Inc.	349,137	$22,564,723
5	INCY	Incyte Corp	226,501	$21,318,272
6	BMRN	Biomarin Pharmaceutical Inc	263,389	$14,878,843
7	EXEL	Exelixis, Inc.	313,945	$13,465,100
8	JAZZ	Jazz Pharmaceuticals plc	45,746	$8,648,280

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$136,251	113,544	+116.3%	Shares	Sole	2026-05-15
2025-12-31	$51,438	52,489	+3.3%	Shares	Sole	2026-02-11
2025-09-30	$64,029	50,817	+63.9%	Shares	Other	2025-10-22
2025-06-30	$34,727	31,007	+3.7%	Shares	Sole	2025-08-13
2025-03-31	$23,624	29,904	-96.4%	Shares	Sole	2025-04-30
2024-12-31	$1,358,171	823,134	+4953.6%	Shares	Sole	2025-02-13
2024-09-30	$57,008	16,288	+1.7%	Shares	Sole	2024-11-12
2024-06-30	$52,532	16,016	-4.7%	Shares	Sole	2024-08-13
2024-03-31	$123,356	16,806	-47.8%	Shares	Sole	2024-05-14
2023-12-31	$120,330	32,174	+0.7%	Shares	Sole	2024-01-26
2023-06-30	$152,082	31,950	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.